In Pharma DJ, Ropes & Gray Partner Examines New Guidelines for Biosimilars Released by the Center for Drug Evaluation (China)

In The News
June 8, 2015

In an article published by Pharma DJ, life sciences partner Katherine Wang examines a new guideline released by the Center for Drug Evaluation (CDE), the technical review body under the China Food and Drug Administration (CFDA), which outlines the regulatory framework for biosimilars, aiming to address clinical needs for biologics in China by improving the accessibility and affordability of innovative products. The article is available here.